Cargando…
Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care?
Autor principal: | López Castro, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SEGG. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139265/ https://www.ncbi.nlm.nih.gov/pubmed/34154837 http://dx.doi.org/10.1016/j.regg.2021.05.002 |
Ejemplares similares
-
Precision medicine for corticotherapy in COVID-19
por: Annane, Djillali, et al.
Publicado: (2022) -
Clinical review: Corticotherapy in sepsis
por: Prigent, Helene, et al.
Publicado: (2004) -
Pulmonary rehabilitation in post-discharge treatment of patients with COVID-19 pneumonia
por: Bi, Yueyang, et al.
Publicado: (2022) -
To: Long-term psychological outcome after discharge from intensive
care
por: Lima-Setta, Fernanda, et al.
Publicado: (2019) -
Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)